Skip to content

Clinical trials

Phase 3 Intermittent Claudication trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Intermittent Claudication Phase: Phase 3 Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20041
20052
20063
20094
20112
20141
20161
20221
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated4
Recruiting2
Unknown status2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ARCA Biopharma, Inc.2
Abbott Medical Devices2
Boston Scientific Corporation2
Kos Pharmaceuticals2
Northwestern University2
ActivBiotics1
Genovate Biotechnology Co., Ltd.,1
Kuopio University Hospital1
Medical Center Alkmaar1
Radboud University Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Intermittent Claudication22
Peripheral Arterial Disease11
Peripheral Vascular Diseases11
Atherosclerosis6
Arterial Occlusive Diseases5
Thrombosis3
Embolism2
Thromboembolism2
Bites and Stings1
Inflammation1

Trials

Showing 76 to 22 of 22. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.